eStudySite

San Diego, United States Founded: 1999 • Age: 27 yrs Acquired By Velocity Clinical Research
Site Management Organization with expertise in conducting infectious disease trials

About eStudySite

eStudySite is a Healthcare company based in San Diego (United States) founded in 1999, and was acquired by Velocity Clinical Research in November 2020. Site Management Organization with expertise in conducting infectious disease trials. eStudySite has raised $6 million across 1 funding round from investors including Velocity Clinical Research, Celerity Partners and TPE Boulder. eStudySite has completed 1 acquisition, including Quest Clinical Research. eStudySite offers products and services including Clinical Trials, Patient Recruitment, and Site Management. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Elligo, Acurian and Inclinix; 3 of its 3 listed competitors have raised funding.

Company details

eStudySite is a Site Management Organization that operates 5 clinical research sites in San Diego, San Francisco, and Las Vegas. The company is capable of conducting a range of in-patient and out-patient studies spanning first-in-humanfirst-in-patient and through to pivotal trials and post-marketing support. It has a 20-bed early phase confinement centre suitable for proof-of-concept trials standard Phase I-Phase IIa trials. The company recruits patients from its network of hospitals, community clinics, and patient organizations. eStudySite claims to have a unique method for rapid enrollment and a proprietary software to quickly mine its patient database. The company claims to have expertise in conducting infectious disease targetted clinical trials spanning antibiotics, antivirals, vaccines, diagnostics, and devices, and also caters to other areas such as dermatology, metabolic disease, CNSpain, surgery, womens health, and orphan diseases, among others.

Key Metrics

Products & Services of eStudySite

eStudySite offers a comprehensive portfolio of products and services, including Clinical Trials, Patient Recruitment, and Site Management.

Clinical Trials
Research Services

Conducts trials for new drugs and therapies in various fields

Patient Recruitment
Engagement Services

Recruits and retains participants for medical studies

Site Management
Operational Services

Manages research facilities and compliance for trials

Funding Insights of eStudySite

eStudySite has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Series A round of $6 million completed in November 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6M
  • Total Rounds 1
  • Last Round Series A β€” $6M
  • First Round $6M

    (Nov 2006)

  • Investors Count 2

All 1 funding rounds of eStudySite with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2006$6MSeries A–Celerity Partners, Ticonderoga Capital
–
Valuation history

3 investors in total: 3 institutional.

Investors in eStudySite

eStudySite has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Velocity Clinical Research, Celerity Partners and TPE Boulder.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Celerity Partners is engaged in building legacy enterprises through investments.
1995celeritypartners.comLos Angeles, United States
Private equity investments are made in profitable software companies.
ticonderogacap.comBoulder, United States
Provider of site management and patient recruitment services
2017velocityclinical.comDurham, United States
Premium access

Investor details for eStudySite

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by eStudySite

eStudySite has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Quest Clinical Research.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of clinical research services studies for phase I, II, and III clinical studies
questclinical.comSan Francisco, United States2011Oct 2015β€’β€’β€’β€’
Premium access

Complete acquisition details for eStudySite

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of eStudySite

4 dated milestones of eStudySite across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded eStudySite is founded.
  2. Funding First funding round of $6.0M.
  3. Acquisition Acquires Quest Clinical Research.
  4. Exit Acquired by Velocity Clinical Research.

Competitors of eStudySite

eStudySite has 3 listed competitors in our database, 3 of them funded. They include Elligo, Acurian and Inclinix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
elligohealthresearch.com2016Austin, United States$176.48M280
Patient recruitment and site activation services are provided by Elligo.
acurian.com1998Horsham, United States$27M
Patient enrollment and retention solutions for clinical trials are offered.
inclinix.com1999Wilmington, United States$10.5M
Customized solutions for clinical trial enrollment are provided.
Premium access

Detailed competitors of eStudySite

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as eStudySite (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about eStudySite

eStudySite was founded in 1999 and raised its 1st funding round 7 years after it was founded.

eStudySite is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

eStudySite is a funded company, having raised a total of $6M across 1 funding round to date. The company's 1st funding round was a Series A of $6M, raised on Nov 2006.

eStudySite is a Site Management Organization that operates 5 clinical research sites in San Diego, San Francisco, and Las Vegas. The company is capable of conducting a range of in-patient and out-patient studies spanning first-in-humanfirst-in-patient and through to pivotal trials and post-marketing support. It has a 20-bed early phase confinement centre suitable for proof-of-concept trials standard Phase I-Phase IIa trials. The company recruits patients from its network of hospitals, community clinics, and patient organizations. eStudySite claims to have a unique method for rapid enrollment and a proprietary software to quickly mine its patient database. The company claims to have expertise in conducting infectious disease targetted clinical trials spanning antibiotics, antivirals, vaccines, diagnostics, and devices, and also caters to other areas such as dermatology, metabolic disease, CNSpain, surgery, womens health, and orphan diseases, among others.

eStudySite's top competitors include Elligo, Acurian and Inclinix.

eStudySite offers Clinical Trials, Patient Recruitment, and Site Management.

eStudySite has made 1 acquisition, including Quest Clinical Research.

eStudySite has 3 investors. Key investors include Velocity Clinical Research, Celerity Partners, and TPE Boulder.

Yes. eStudySite was acquired by Velocity Clinical Research in November 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available